TokenPost
Cover art for Jaguar Health Targets Mid-2027 MVID Filing

Jaguar Health Targets Mid-2027 MVID Filing

Jaguar Health aims for mid-2027 drug submission after $10m debt cut.

Nov 17, 2026

3 cards · 40s · tap to begin

From · · 40s

Jaguar Health Targets Mid-2027 MVID Filing

Jaguar Health aims for mid-2027 drug submission after $10m debt cut.

In brief

Jaguar Health aims for mid-2027 drug submission after $10m debt cut. Jaguar Health plans mid-2027 new drug application for pediatric MVID treatment after reducing debt by over $10 million. Originally reported by TokenPost.

Jaguar Health Targets MVID Filing

Jaguar Health plans mid-2027 new drug application for crofelemer to treat pediatric MVID after completing pivotal-trial enrollment.

Debt Reduction Milestone

Jaguar reduced outstanding debt by more than $10 million in Q3 2026, with $2.343 million revenue and $9.23 net loss per share.

Next Milestone

Jaguar targets mid-2027 NDA submission and seeks FDA breakthrough therapy designation for faster review.

At a glance

Jaguar Health plans mid-2027 new drug application for pediatric MVID treatment after reducing debt by over $10 million.

Read the original on TokenPost

Read the TL;DR — this story on one card.

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on jaguar health and related topics.